A clinical prediction model for definite multiple sclerosis in patients with clinically isolated syndrome

被引：0
|
作者：
Runia, T. F. [1 ]
Jafari, N. [1 ]
Siepman, D. A. M. [1 ]
Nieboer, D. [2 ]
Steyerberg, E. [2 ]
Hintzen, R. Q. [1 ]
机构：
[1] Erasmus MC, Neurol, Rotterdam, Netherlands
[2] Erasmus MC, Biostat, Rotterdam, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P768
引用
收藏
页码：404 / 404
页数：1
相关论文
共 50 条
  • [21] Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome
    Zetterberg, Henrik
    Svenningsson, Anders
    NEUROLOGY, 2019, 92 (07) : 313 - 314
  • [22] Prognostic value of oligoclonal IgG bands in Japanese clinically isolated syndrome converting to clinically definite multiple sclerosis
    Kinoshita, Masako
    Daifu, Masako
    Tanaka, Keiko
    Tanaka, Masami
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 307 : 1 - 6
  • [23] Influence of HLA DR2 on progression from clinically isolated syndrome to clinically definite multiple sclerosis
    De las Heras, V.
    Bartolome, M.
    Mas, A.
    Martinez, A.
    Urcelay, E.
    Gomez de la Concha, E.
    Arroyo, R.
    MULTIPLE SCLEROSIS, 2006, 12 : S76 - S76
  • [24] Multiple Sclerosis Lesions Evolution in Patients with Clinically Isolated Syndrome
    Crimi, A.
    Commowick, O.
    Ferre, J. C.
    Maarouf, A.
    Edan, G.
    Barillot, C.
    MEDICAL IMAGING 2013: IMAGE PROCESSING, 2013, 8669
  • [25] CSF proteome analysis in clinically isolated syndrome: candidate markers for conversion to definite multiple sclerosis
    Tumani, H.
    Lehmensiek, V.
    Rau, D.
    Guttmann, I.
    Tauscher, G.
    Sapunova-Meier, I.
    Mogel, H.
    Ludolph, A.
    Brettschneider, J.
    JOURNAL OF NEUROLOGY, 2009, 256 : S35 - S35
  • [26] CSF Proteome Analysis in Clinically Isolated Syndrome (CIS): Biomarkers for Conversion to Definite Multiple Sclerosis
    Tumani, Hayrettin
    Lehmensiek, Vera
    Rau, Daniela
    Guttmann, Ivonne
    Palm, Christian
    Suessmuth, Sigurd D.
    Brettschneider, Johannes
    NEUROLOGY, 2009, 72 (11) : A197 - A197
  • [27] Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis
    Brettschneider, J
    Petzold, A
    Junker, A
    Tumani, H
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (02) : 143 - 148
  • [28] RADIOLOGICAL BUT NOT CLINICAL CONVERSION TO MULTIPLE SCLEROSIS FOLLOWING A CLINICALLY ISOLATED SYNDROME
    Chard, D. T.
    Swanton, J. K.
    Dalton, C. M.
    Fernando, K. T.
    Miszkiel, K. A.
    Plant, G. T.
    Thompson, A. J.
    Miller, D. H.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (11):
  • [29] Individual prediction of clinically definite MS in patients presenting with clinically isolated syndrome using machine learning
    Wottschel, V.
    Alexander, D. C.
    Chard, D. T.
    Enzinger, C.
    Filippi, M.
    Frederiksen, J. L.
    Gasperini, C.
    Giorgio, A.
    Rocca, M.
    Rovira, A.
    De Stefano, N.
    Tintore, M.
    Miller, D. H.
    Ciccarelli, O.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 401 - 402
  • [30] Comparison of lesion distribution in children with clinically isolated syndromes at risk for multiple sclerosis and adults with clinically definite multiple sclerosis
    Ghassemi, R.
    Antel, S.
    Francis, S. J.
    Banwell, B.
    Arnold, D. L.
    MULTIPLE SCLEROSIS, 2007, 13 (09): : 1232 - 1232
12345